These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22465074)

  • 1. The Bcl6-SMRT/NCoR cistrome represses inflammation to attenuate atherosclerosis.
    Barish GD; Yu RT; Karunasiri MS; Becerra D; Kim J; Tseng TW; Tai LJ; Leblanc M; Diehl C; Cerchietti L; Miller YI; Witztum JL; Melnick AM; Dent AL; Tangirala RK; Evans RM
    Cell Metab; 2012 Apr; 15(4):554-62. PubMed ID: 22465074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways.
    Ghisletti S; Huang W; Jepsen K; Benner C; Hardiman G; Rosenfeld MG; Glass CK
    Genes Dev; 2009 Mar; 23(6):681-93. PubMed ID: 19299558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
    Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages.
    Nazari-Jahantigh M; Wei Y; Noels H; Akhtar S; Zhou Z; Koenen RR; Heyll K; Gremse F; Kiessling F; Grommes J; Weber C; Schober A
    J Clin Invest; 2012 Nov; 122(11):4190-202. PubMed ID: 23041630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages.
    Mondal A; Sawant D; Dent AL
    J Immunol; 2010 Apr; 184(8):4123-32. PubMed ID: 20212093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
    Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
    Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics analysis of the interaction between the human BCL6 BTB domain and its SMRT, NcoR and BCOR corepressors: the quest for a consensus dynamic pharmacophore.
    Granadino-Roldán JM; Obiol-Pardo C; Pinto M; Garzón A; Rubio-Martínez J
    J Mol Graph Model; 2014 May; 50():142-51. PubMed ID: 24793055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
    Ahmad KF; Melnick A; Lax S; Bouchard D; Liu J; Kiang CL; Mayer S; Takahashi S; Licht JD; Privé GG
    Mol Cell; 2003 Dec; 12(6):1551-64. PubMed ID: 14690607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of NCOR/SMRT Repressor Complexes with Papillomavirus E8^E2C Proteins Inhibits Viral Replication.
    Dreer M; Fertey J; van de Poel S; Straub E; Madlung J; Macek B; Iftner T; Stubenrauch F
    PLoS Pathog; 2016 Apr; 12(4):e1005556. PubMed ID: 27064408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl6 is a transcriptional repressor for the IL-18 gene.
    Takeda N; Arima M; Tsuruoka N; Okada S; Hatano M; Sakamoto A; Kohno Y; Tokuhisa T
    J Immunol; 2003 Jul; 171(1):426-31. PubMed ID: 12817026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain.
    Evans SE; Goult BT; Fairall L; Jamieson AG; Ko Ferrigno P; Ford R; Schwabe JW; Wagner SD
    PLoS One; 2014; 9(3):e90889. PubMed ID: 24595451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
    Cerchietti LC; Yang SN; Shaknovich R; Hatzi K; Polo JM; Chadburn A; Dowdy SF; Melnick A
    Blood; 2009 Apr; 113(15):3397-405. PubMed ID: 18927431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
    Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
    Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
    Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
    J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
    Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1.
    Yang Y; Yang L; Liang X; Zhu G
    Cell Physiol Biochem; 2015; 36(4):1371-81. PubMed ID: 26159489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
    Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
    Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl6 in pulmonary epithelium coordinately controls the expression of the CC-type chemokine genes and attenuates allergic airway inflammation.
    Seto T; Yoshitake M; Ogasawara T; Ikari J; Sakamoto A; Hatano M; Hirata H; Fukuda T; Kuriyama T; Tatsumi K; Tokuhisa T; Arima M
    Clin Exp Allergy; 2011 Nov; 41(11):1568-78. PubMed ID: 21801248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.